Researchers assessed CSX-1004, a monoclonal antibody (mAb), for its efficacy in reversing fentanyl overdose based on its high affinity for fentanyl, positive animal model results, and safe pharmacokinetic profile, positioning it as a potential solution in the opioid crisis.
Corundum Neuroscience Launches Neuroscience Venture Builder & Fund
What You Should Know: – Corundum Neuroscience, formerly Joy Ventures launches a new neuroscience-focused venture builder and fund to spur neuroscience research and innovation. –
November 9, 2023